Geno1™

Remove bottlenecks, save lives

Reduced
cost

Direct cost savings as well as indirect effects created by increased diagnostics accuracy.

Increased
accuracy

The unique combination of molecular biology, robotics, NGS and AI provides market-leading accuracy.

Faster
turn-around-time

Manual stages of work almost fully minimized, enabling unparallelled scalability and processing times.

Geno1™ in detail

Geno1™  is a pre-sequencing technology that combines molecular biology, robotics, next-generation DNA sequencing (NGS) and artificial intelligence (AI).

Geno1™ addresses the key shortcomings of NGS-based solutions through its minimalistic but powerful design, leading to substantially lower test costs, higher test accuracy and faster turn-around-time. Geno1™ is also massively scalable technology.

Geno1™ unlocks the use of NGS in an unprecedented way and democratises the precision diagnostics.

Minimize to maximize

Our unique ligation-based molecular barcoding Geno1 technology maximizes the power of NGS platforms and AI. The laboratory design of Geno1™ has been guided by the principle of minimalism: reduce all processing steps to minimum and make them as simple as possible. Through these design choices, Geno1™ provides a lightweight but powerful molecular counting platform which scales to any number of relevant targets within any number of patient samples. 

 

Join our journey

 We offer Geno1™ for out-licensing and are continuously looking for new long-term partnerships both within oncology and other verticals.

Join us in democratizing true game-changing technology!